Prostat Kanseri Hücreleri Üzerinde Protokatekuik Asitin Büyümeyi Önleyici ve Apoptoz İndükleyici Etkilerinin Belirlenmesi
Abstract
Keywords
References
- Abe, K., Matsuki, N. (2000). Measurement of cellular 3-(4,5-dimetiltriazol-2-il)-2,5-difeniltetrazolium bromid (MTT) reduction activity and lactate dehydrogenase release using MTT, Neuroscience Research, 38, 325-329.
- Aydın, Ç., Taşdelen, Ö. G., Turan, M., Mammadov, R. (2016). Phenolic Contents and Antioxidant Properties of Echinops ritro L. and E. tournefortii Jaup. Et. Spach Extract, International Journal of Seconder Metabolite, 3(2), 74-81.
- Hwang, C. (2012). Overcoming docetaxel resistance in prostate cancer: A perspective review, Therapeutic Advances in Medical Oncology, 4, 329-340.
- Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., Forman, D. (2011). Global Cancer Statistics. Cancer Journal for Clinicians, 61(2), 69-90.
- Kakkar, S., Bais, S. (2014). A Review on Protocatechuic Acid and Its Pharmacological Potential, ISRN Pharmacology, 34, 1-9.
- Kawabata, R., S, Oie., Takahashi, M., Kanayama, H., Oka, T., Itoh, K. (2011). Up- regulation of insulin- like growth factor- binding protein 3 by 5-fluorouracil (5-FU) leads to the potent anti- proliferative effects of androgen deprivation therapy combined with 5-FU in human prostate cancer cell lines, International Journal of Oncology, 38, 1489-1500.
- Khan, A. K., Rashid, R., Fatima, N., Mahmood, S., Mir, S., Khan, S., Jabeen, N., Murtaza, G. (2015). Pharmacological Activities of Protocatechuic acid, Acta Poloniae Pharmaceutica, 72(4), 643-650.
- Komissarova, E. V., Saha, S. K., Rossman, T. G. (2005). Dead or dying: the importance of time in cytotoxicity assays using arsenite as an example, Toxicology and Applied Pharmacology, 202, 99-107.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Publication Date
January 1, 2018
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2018 Volume: 11 Number: 1